Shiva Texyarn Management Change
Shiva Texyarn names Sri G K Raman, President-Strategic Affairs, as resigned w.e.f. 31 Oct 2026. The departure of this senior management person is disclosed under LODR Regulation 30.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
10 announcements with these filters
Shiva Texyarn names Sri G K Raman, President-Strategic Affairs, as resigned w.e.f. 31 Oct 2026. The departure of this senior management person is disclosed under LODR Regulation 30.
Shiva Texyarn scheduled its Board meeting for 12 November 2026. The agenda is to consider and approve un-audited results for the quarter and half year ended 30 September 2026.
Shiva Texyarn Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI listing regulations.
Promoter Vedanayagam Hospital Private Limited sold 1,50,000 equity shares of Shiva Texyarn Ltd via an off-market inter-se transfer valued at ₹2.39 Crore.
Vedanayagam Hospital Pvt Ltd, a promoter, inter-se transferred 1,50,000 Shiva Texyarn shares, cutting its stake from 66.04% to 64.88%. No separate consideration was disclosed for the transfer.
S K Sundararaman, a Shiva Texyarn promoter, acquired 1,50,000 shares via inter-se transfer. His stake rose from 0.39% to 1.55% of total voting capital.
Shiva Texyarn promoter Sundararaman acquired 1.5 lakh shares at Rs.159.53 from fellow promoter Vedanayagam Hospital Private Ltd. The inter-se transfer lifts his stake to 1.55%.
Promoter S K Sundararaman proposes to acquire 1,50,000 equity shares (1.16%) of Shiva Texyarn Ltd via an inter-se transfer. The transaction involves M/s. Vedanayagam Hospital Private Limited.
CARE Ratings has upgraded the credit ratings for Shiva Texyarn Ltd's bank facilities totaling ₹202.58 Crore. This reflects improved creditworthiness for the company.
Shiva Texyarn Limited conducted its 45th Annual General Meeting on August 27, 2026. Key resolutions included adopting audited financial statements and declaring a 6% equity dividend.